Distinguished in Narcolepsy

Dr. Thomas P. Stern

Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Forsyth Medical Group, LLC
360 9th Ave Dr Ne, 
Hickory, NC 
Accepting New Patients
Offers Telehealth
Distinguished in Narcolepsy
Forsyth Medical Group, LLC
360 9th Ave Dr Ne, 
Hickory, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Thomas Stern is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Hickory, North Carolina. Dr. Stern is rated as a Distinguished provider by MediFind in the treatment of Narcolepsy. His top areas of expertise are Drowsiness, Narcolepsy, Excessive Daytime Sleepiness, and Obstructive Sleep Apnea. Dr. Stern is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 4 clinical trials in the study of Narcolepsy.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Sleep Medicine
Licenses
Critical Care Medicine in NC
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

FORSYTH MEDICAL GROUP, LLC
360 9th Ave Dr Ne, Hickory, NC 28601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Enrollment Status: Completed
Publish Date: October 02, 2025
Intervention Type: Drug
Study Phase: Phase 3
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Biological
Study Drug: Depemokimab
Study Phase: Phase 3
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
Enrollment Status: Completed
Publish Date: March 13, 2023
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
The Effect of the DryMouth Shield on Snoring
The Effect of the DryMouth Shield on Snoring
Enrollment Status: Terminated
Publish Date: April 27, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Enrollment Status: Completed
Publish Date: November 12, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
View 6 Less Clinical Trials

3 Total Publications

RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates.
RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates.
Journal: Sleep medicine: X
Published: May 23, 2024
Similar Doctors
Distinguished in Narcolepsy
Dr. Kenneth T. Ashkin
Neurology | Sleep Medicine
Distinguished in Narcolepsy
Dr. Kenneth T. Ashkin
Neurology | Sleep Medicine
10009 Park Cedar Dr, Suite 100, 
Charlotte, NC 
 (53.7 miles away)
704-412-7859
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Kenneth Ashkin is a Neurologist and a Sleep Medicine provider in Charlotte, North Carolina. Dr. Ashkin is rated as a Distinguished provider by MediFind in the treatment of Narcolepsy. His top areas of expertise are Narcolepsy, Obstructive Sleep Apnea, Central Sleep Apnea, and Periodic Limb Movement Disorder. Dr. Ashkin is currently accepting new patients.

Mark Letica
Advanced in Narcolepsy
Dr. Mark Letica
Sleep Medicine
Advanced in Narcolepsy
Dr. Mark Letica
Sleep Medicine

Atrium Health Sleep Medicine

431 Copperfield Blvd. NE, 
Concord, NC 
 (46.7 miles away)
704-403-9300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Letica is a Sleep Medicine provider in Concord, North Carolina. Dr. Letica is rated as an Advanced provider by MediFind in the treatment of Narcolepsy. His top areas of expertise are Obstructive Sleep Apnea, Narcolepsy, Central Sleep Apnea, and Periodic Limb Movement Disorder. Dr. Letica is currently accepting new patients.

Advanced in Narcolepsy
Dr. Farhan A. Siddiqui
Pulmonary Medicine | Intensive Care Medicine
Advanced in Narcolepsy
Dr. Farhan A. Siddiqui
Pulmonary Medicine | Intensive Care Medicine

Upstate Lung And Critical Care Specialists PC

1529 N Limestone St, 
Gaffney, SC 
 (50.3 miles away)
864-487-9931
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Farhan Siddiqui is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Gaffney, South Carolina. Dr. Siddiqui is rated as a Distinguished provider by MediFind in the treatment of Narcolepsy. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Obstructive Sleep Apnea, Bronchiectasis, and Gastrostomy. Dr. Siddiqui is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stern's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile